1. Home
  2. NMRK vs HAE Comparison

NMRK vs HAE Comparison

Compare NMRK & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMRK
  • HAE
  • Stock Information
  • Founded
  • NMRK 1929
  • HAE 1971
  • Country
  • NMRK United States
  • HAE United States
  • Employees
  • NMRK N/A
  • HAE N/A
  • Industry
  • NMRK Real Estate
  • HAE Medical/Dental Instruments
  • Sector
  • NMRK Finance
  • HAE Health Care
  • Exchange
  • NMRK Nasdaq
  • HAE Nasdaq
  • Market Cap
  • NMRK 3.2B
  • HAE 3.3B
  • IPO Year
  • NMRK 2017
  • HAE 1991
  • Fundamental
  • Price
  • NMRK $19.28
  • HAE $52.21
  • Analyst Decision
  • NMRK Strong Buy
  • HAE Buy
  • Analyst Count
  • NMRK 5
  • HAE 10
  • Target Price
  • NMRK $17.50
  • HAE $84.20
  • AVG Volume (30 Days)
  • NMRK 1.3M
  • HAE 945.0K
  • Earning Date
  • NMRK 11-04-2025
  • HAE 11-06-2025
  • Dividend Yield
  • NMRK 0.62%
  • HAE N/A
  • EPS Growth
  • NMRK 44.43
  • HAE 46.89
  • EPS
  • NMRK 0.36
  • HAE 3.28
  • Revenue
  • NMRK $2,983,234,000.00
  • HAE $1,346,046,000.00
  • Revenue This Year
  • NMRK $16.96
  • HAE N/A
  • Revenue Next Year
  • NMRK $9.43
  • HAE $6.50
  • P/E Ratio
  • NMRK $53.58
  • HAE $15.93
  • Revenue Growth
  • NMRK 17.28
  • HAE 0.91
  • 52 Week Low
  • NMRK $9.65
  • HAE $50.68
  • 52 Week High
  • NMRK $19.70
  • HAE $94.99
  • Technical
  • Relative Strength Index (RSI)
  • NMRK 75.40
  • HAE 30.00
  • Support Level
  • NMRK $17.29
  • HAE $53.10
  • Resistance Level
  • NMRK $18.90
  • HAE $54.52
  • Average True Range (ATR)
  • NMRK 0.48
  • HAE 1.22
  • MACD
  • NMRK -0.02
  • HAE 0.53
  • Stochastic Oscillator
  • NMRK 82.52
  • HAE 7.61

About NMRK Newmark Group Inc.

Newmark Group Inc is a commercial real estate advisory firm. It offers services, including leasing and corporate advisory services, investment sales, commercial mortgage brokerage, appraisal and valuation, project management, and property, among others. Newmark offers a diverse array of integrated services and products designed to meet the full needs of both real estate investors/owners and occupiers. The company provides real estate strategic consulting and systems integration services to CFI's clients including many Fortune and Forbes companies, owner-occupiers, government agencies, healthcare, and higher education clients.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: